Celltrion, “Janssen’s Remsima patent infringement lawsuit is unreasonable”

When it comes to the Janssen’s Remsima patent infringement lawsuit(request to accelerate screening), Celltrion argued the US7,598,083 is a patent related to a badge containing the total 61 types of substances in a specific range of concentration to cultivate antibodies, and what some of the press released is not true although they mentioned the patent is about the composition structure of Remic...